Achilles Therapeutics plc

ACHL Stock Healthcare Biotechnology
$1.48
+0.00 (+0.00%)
Price as of Oct 15, 2026 market close

Performance

1 Month
+18.6%
3 Months
+18.6%
YTD
+0.0%
1 Year
+38.1%
3 Year annualized
+17.8%
5 Year annualized
-27.9%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
37.9%
Largest decline max drawdown, last 5 years
-90.8%
Risk-adjusted return Sharpe ratio, 1-year
1.03

Own ACHL?

See how ACHL contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.